GT Biopharma Inc reports results for the quarter ended in June - Earnings Summary

GT Biopharma

23/08/2021 22:14

* GT Biopharma Inc  GTBP.OQ  reported a quarterly adjusted loss
of 13 cents​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 28 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* GT Biopharma Inc's reported EPS for the quarter was a loss
of 15 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* GT Biopharma Inc shares had fallen by 51.2% this quarter and
gained 5.0% so far this year.
* The company reported a quarterly loss of $4.86 million.
* Wall Street's median 12-month price target for GT Biopharma
Inc is $25.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 23 at 09:14 p.m.  ​All
figures in US dollars unless otherwise stated